TRERF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.441600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.718200E-01
Normal-vs-Stage2
2.595200E-01
Normal-vs-Stage3
2.749200E-01
Normal-vs-Stage4
8.657000E-01
Stage1-vs-Stage2
4.606200E-01
Stage1-vs-Stage3
8.136100E-02
Stage1-vs-Stage4
3.087000E-01
Stage2-vs-Stage3
5.586400E-02
Stage2-vs-Stage4
3.928000E-01
Stage3-vs-Stage4
1.788030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.652400E-01
Normal-vs-AfricanAmerican
1.783610E-01
Normal-vs-Asian
3.484400E-01
Caucasian-vs-AfricanAmerican
2.025600E-01
Caucasian-vs-Asian
6.535600E-01
AfricanAmerican-vs-Asian
4.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.379000E-01
Normal-vs-Female
5.440600E-01
Male-vs-Female
3.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.791200E-01
Normal-vs-Age(41-60Yrs)
4.444800E-01
Normal-vs-Age(61-80Yrs)
5.226800E-01
Normal-vs-Age(81-100Yrs)
5.542000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.850200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.471000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.793200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.045800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.189400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.155000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.145000E-01
Normal-vs-Daily Drinker
3.105200E-01
Normal-vs-Weekly Drinker
1.964850E-01
Normal-vs-Occasional Drinker
9.335400E-01
Normal-vs-Social Drinker
4.432600E-01
Non Drinker-vs-Daily Drinker
8.587000E-01
Non Drinker-vs-Weekly Drinker
4.542400E-01
Non Drinker-vs-Occasional Drinker
2.929500E-02
Non Drinker-vs-Social Drinker
2.941800E-01
Daily Drinker-vs-Weekly Drinker
5.833600E-01
Daily Drinker-vs-Occasional Drinker
3.330300E-02
Daily Drinker-vs-Social Drinker
4.096200E-01
Weekly Drinker-vs-Occasional Drinker
1.708210E-02
Weekly Drinker-vs-Social Drinker
8.147400E-01
Occasional Drinker-vs-Social Drinker
4.419400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.158820E-01
Normal-vs-Grade 2
2.800000E-02
Normal-vs-Grade 3
1.582210E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.448090E-02
Grade 1-vs-Grade 3
3.039200E-03
Grade 1-vs-Grade 4
1.158820E-01
Grade 2-vs-Grade 3
3.262600E-01
Grade 2-vs-Grade 4
2.800000E-02
Grade 3-vs-Grade 4
1.582210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.348400E-01
Normal-vs-NonDiabetic
2.629400E-01
Diabetic-vs-NonDiabetic
5.925200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.921600E-01
Normal-vs-NoPancreatitis
2.494400E-01
Pancreatitis-vs-NoPancreatitis
2.680200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.798190E-01
Normal-vs-N1
2.873400E-01
N0-vs-N1
3.310600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.297600E-01
Normal-vs-TP53-NonMutant
3.934800E-01
TP53-Mutant-vs-TP53-NonMutant
7.995400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
